Shattuck Labs, Inc. (STTK) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US82024L1035
Shattuck Labs, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.00 m USD |
| Operating income | -51.51 m USD |
| EBIT | -51.51 m USD |
| Net income | -48.81 m USD |
| Diluted EPS – continuing operations | -0.70 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shattuck Labs, Inc.
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.
More stocks
- Norma Group (NOEJ.DE)
- Juventus FC SpA (JUVE.MI)
- HYSTER-YALE, INC. (HY)
- Bhakti Multi Artha Pt (BHAT.JK)
- Ningbo Daye Garden Machinery Co Ltd (300879.SZ)
- Colorlight Cloud Tech Ltd. A (301391.SZ)
- Nantong Xingqiu Graphite Co. Ltd. A (688633.SS)
- Sinosun Tech (300333.SZ)
- Simei Media Co Ltd (002712.SZ)
- Qinghai Huzhu Barley Wine Co Ltd (002646.SZ)
- Jiangxi Chen Guang New Materials Co Ltd (605399.SS)
- BitGo Holdings, Inc. (BTGO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.